Newsletter | February 4, 2021

02.04.21 -- Will Biosimilars Mean Business In 2021?

Featured Editorial
Industry Insights
Accelerate Process Intensification For Viral Vaccine Manufacturing

This article details an integrated portfolio of technologies to facilitate process intensification of viral-based vaccines including SARS-CoV-2 (COVID-19) vaccine candidates.

Enhanced Host Cell Protein Analysis In Biologics Manufacturing

Enzyme-linked immunosorbent assays (ELISAs) to monitor host cell protein levels are challenging. This article illustrates an enhanced antihost cell protein antibody coverage analysis method solution.

News Headlines
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.